Science & Enterprise subscription

Follow us on Twitter

  • A company developing graphene bio-computer chips is applying its technology to sensors that quickly detect SARS-CoV… https://t.co/Gl4q8GAZBg
    about 3 hours ago
  • New post on Science and Enterprise: Sensor in Works Detecting Covid-19 Airborne Virus https://t.co/gQ7LuZ5Qv1 #Science #Business
    about 3 hours ago
  • A company designing microscale robotic devices to deliver therapies to the central nervous system began work in pub… https://t.co/SUbHXwULXG
    about 5 hours ago
  • New post on Science and Enterprise: Micro Robotic Neuro Therapy Company Underway https://t.co/Lfm9Nysgd3 #Science #Business
    about 5 hours ago
  • National Science Foundation is funding a new system that uses artificial intelligence to find optimal combinations… https://t.co/jbZAJqQpmT
    about 1 day ago

Please share Science & Enterprise

Biotech, UK Govt to Design Covid-19 Variant Vaccines

Vaccine vials

A biotechnology company and a U.K. government agency agreed to quickly develop and produce vaccines to protect against emerging Covid-19 viral mutations. . . . → Read More: Biotech, UK Govt to Design Covid-19 Variant Vaccines

One-Dose Covid-19 Vaccine Shown to Prevent Hospitalization

Syringe in hand

Results from four international clinical trials show high disease prevention rates from one dose of the Oxford-AstraZeneca Covid-19 vaccine. . . . → Read More: One-Dose Covid-19 Vaccine Shown to Prevent Hospitalization

Cancer Immunotherapy Adapted for HIV

T-cell infected by HIV

A biotechnology company is adapting and licensing its immunotherapy process, originally designed for cancer, as a cure for HIV infections. . . . → Read More: Cancer Immunotherapy Adapted for HIV

Institutions Join Global Health Breakthrough Network

Networked earth

Wellcome Leap aims to establish a model for faster design and development of health breakthroughs, beginning with elimination of administrative obstacles. . . . → Read More: Institutions Join Global Health Breakthrough Network

Trial Testing Multi-Company Covid-19 Therapy

SARS-Cov-2 virus

A clinical trial already underway is expanding to test a combination of two synthetic antibodies from different companies as a treatment for Covid-19 infections. . . . → Read More: Trial Testing Multi-Company Covid-19 Therapy

Patient Database Offered for Covid-19 Research Group

Code on screen

A large health care system is offering data from its Covid-19 patient registry to a consortium of government and academic research labs. . . . → Read More: Patient Database Offered for Covid-19 Research Group

CubeSats to Test Satellite Group Signaling

V-R3X CubeSat

A university robotics lab built three small space satellites for NASA to test radio transmissions in autonomous groups or swarms for more sophisticated future missions. . . . → Read More: CubeSats to Test Satellite Group Signaling

Antibodies Prevent Covid-19 Symptoms in Long-Term Care

Mobile lab team

A clinical trial shows long-term care residents and staff receiving a synthetic antibody treatment have a lower risk of getting symptomatic Covid-19 infections. . . . → Read More: Antibodies Prevent Covid-19 Symptoms in Long-Term Care

Multi-Variant Covid-19 Vaccine in the Works

SARS-CoV-2 and cell

A vaccine protecting against multiple Covid-19 viral variations is in development, with an early-stage clinical trial expected to begin soon. . . . → Read More: Multi-Variant Covid-19 Vaccine in the Works

Universities Form Joint Engineering Patent Pool

U.S. Patent and Trademark Office

A group of 15 American universities are putting part of their engineering patents into a common licensing pool for commercial development. . . . → Read More: Universities Form Joint Engineering Patent Pool